Cumulative incidence of relapse (mean ± SE) among 379 children with B-lineage ALL whose MRD levels were less than 0.01% on day 46 (end of remission induction therapy). Patients with MRD 0.001% to less than 0.01% had a significantly higher incidence of relapse than those with lower levels or undetectable MRD by PCR.